Search
70 result(s) for 'author#Nicolas H. Hart' within BMC
Page 1 of 4
Sort by: Relevance | Date
-
Citation: Journal for ImmunoTherapy of Cancer 2019 7(Suppl 1):282
-
34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 2
Citation: Journal for ImmunoTherapy of Cancer 2019 7(Suppl 1):283 -
Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Citation: Pediatric Rheumatology 2018 16(Suppl 2):52 -
Abstracts of the XX World Allergy Congressâ„¢ 2007 December 2-6, 2007, Bangkok, Thailand
Citation: World Allergy Organization Journal 2007 1(Suppl 3):132 -
28th Annual Computational Neuroscience Meeting: CNS*2019
Citation: BMC Neuroscience 2019 20(Suppl 1):56 -
Abstract withdrawn
Citation: Critical Care 2010 14(Suppl 1):P266 -
Abstract withdrawn
Citation: Critical Care 2010 14(Suppl 1):P563 -
Abstract withdrawn
Citation: Critical Care 2010 14(Suppl 1):P293 -
Abstract withdrawn
Citation: Critical Care 2010 14(Suppl 1):P299 -
Abstract withdrawn
Citation: Critical Care 2010 14(Suppl 1):P564 -
Reviewer acknowledgement 2015
The editors of BMC Public Health would like to thank all our reviewers who have contributed to the journal in Volume 15 (2015).
Citation: BMC Public Health 2016 16:189 -
Proceedings of the 13th annual conference of INEBRIA
Citation: Addiction Science & Clinical Practice 2016 11(Suppl 1):13 -
Abstract withdrawn
Citation: Critical Care 2013 17(Suppl 2):P441 -
Abstract withdrawn
Citation: Critical Care 2013 17(Suppl 2):P65 -
Abstract withdrawn
Citation: Critical Care 2013 17(Suppl 2):P438 -
Abstract withdrawn
Citation: Critical Care 2013 17(Suppl 2):P268 -
Abstract withdrawn
Citation: Critical Care 2013 17(Suppl 2):P384 -
Abstract withdrawn
Citation: Critical Care 2013 17(Suppl 2):P350 -
Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library
In recent years, large-scale genetic screens using the CRISPR/Cas9 system have emerged as scalable approaches able to interrogate gene function with unprecedented efficiency and specificity in various biologic...
Citation: BMC Biology 2020 18:174 -
Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)
Survival rates for lymphoma are highest amongst hematological malignancies. In 2019, it was estimated that over 6400 Australians were diagnosed with lymphoma, a group of hematological malignancies with a high ...
Citation: Trials 2021 22:12